| Name | Title | Contact Details |
|---|
ALFA International is the premier global network for independent law firms. Founded in 1980, it was the first and continues to be one of the largest and strongest legal networks. We have 140 member firms throughout the world. Our 80 US firms maintain offices in 95 of the 100 largest metropolitan areas. Our 60 international firms are located throughout Europe, Asia, Australia/New Zealand, Africa, Canada, Mexico and South America. ALFA Internationals mission is to provide high quality, cost-efficient legal services wherever our clients need them. The ALFA International model enables our members to use their local expertise to deliver highly effective legal solutions, often drawing upon the collective wisdom and experience of other member firms. ALFA International clients have the benefit of a geographically comprehensive network of exceptional law firms and accomplished trial and business counsel. Our member firms meet high standards to be part of the ALFA International network and are well respected by their peers. Our members establish broad, deep relationships with each other by attending ALFA International CLE seminars throughout the year and working together on compendia, seminar programming, and most importantly, client matters. As a result, referrals among ALFA International firms represent partnerships between trusted friends and colleagues. Our many events also provide corporate counsel with the opportunity to network among ALFA International lawyers and their peer in-house lawyers. In addition to the Practice Groups below, our member firms also have expertise in Admiralty & Maritime, Alternative Dispute Resolution, Antitrust & Trade Regulation, Bankruptcy, Corporate & Securities, Environmental Law, Estate Planning & Wealth Transfer, Foreign Investment, Government Relations, Lobbying, & Administrative Law, Immigration, M&A, Oil & Gas, Tax & Venture Capital & Financing. To learn more, please visit us at www.alfainternational.com.
Jordan & Skala Engineers is a leading consulting-engineering firm that specializes in mechanical, electrical, and plumbing (MEP) engineering services. Founded in 1953 and headquartered in Norcross, GA, the company operates multiple regional design offices across the United States, allowing it to effectively meet the diverse needs of its clients. With a workforce of approximately 310 employees, Jordan & Skala Engineers is licensed to operate in all 50 states. The firm offers a wide range of services, including MEP engineering, structured cabling for communications, security system design, audio-visual solutions, and comprehensive energy services aimed at promoting sustainability. Additionally, the company conducts facility assessments to optimize existing buildings. Jordan & Skala Engineers is committed to engineering excellence, focusing on quality, safety, and strong client relationships through teamwork and innovative designs. The company has been recognized as a Top U.S. Workplace in 2023, underscoring its dedication to employee satisfaction and industry leadership.
The National Basketball Association (NBA) is a professional sports league in North America, established in 1946. Headquartered in New York City, the NBA is one of the four major professional sports leagues in the United States and Canada. It is known for its competitive basketball games, iconic players, and extensive global reach. The NBA organizes regular season games, playoffs, and the NBA Finals, attracting millions of viewers worldwide. It also oversees the NBA G League, which serves as a developmental platform for players and staff, and runs Jr. NBA programs to promote basketball among youth. The league is committed to community outreach through NBA Cares, focusing on building facilities and supporting education and health initiatives. With a strong presence in over 200 countries, the NBA utilizes advanced technology and media platforms to engage fans and enhance their experience.
IMUNON is a fully integrated, clinical stage biotechnology company focused on advancing a portfolio of innovative treatments that harness the bodys natural mechanisms to generate safe, effective, and durable responses across a broad array of human diseases. IMUNON has two platform technologies: Our TheraPlas® platform for the development of immunotherapies and other anti-cancer nucleic acid-based therapies and our PLACCINE platform for the development of nucleic acid vaccines for infectious diseases and cancer. The Companys lead clinical program, GEN-1, is a DNA-based immunotherapy for the localized treatment of advanced ovarian cancer currently in Phase II development. GEN-1 works by instructing the body to produce safe and durable levels of powerful cancer fighting molecules, such as interleukin-12 (IL-12) and interferon gamma (IFN-γ), at the tumor site. In addition, we are conducting pre-clinical proof-of-concept studies on a nucleic acid vaccine candidate targeting SARS-CoV-2 virus in order to validate our PLACCINE platform. IMUNONs platform technologies are based on the delivery of nucleic acids with novel synthetic delivery systems that are independent of viral vectors or devices. We will continue to leverage these platforms and to advance the technological frontier of plasmid DNA to better serve patients with difficult to treat conditions.